2021 annual financial data
AbCellera Biologics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 2,106.39%.
Operating income was -4,117,008 USD and net income was -2,210,696 USD.
Operating cash flow was 244,584,000 USD.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,611,543 USD
- Operating income
- -4,117,008 USD
- Net income
- -2,210,696 USD
- Operating cash flow
- 244,584,000 USD